/
/
/

Aarey Drugs & Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹45 Cr₹189 Cr₹96 Cr₹84 Cr₹102 Cr₹108 Cr₹134 Cr₹105 Cr₹127 Cr₹210 Cr₹76 Cr₹58 Cr₹51 Cr₹158 Cr₹62 Cr₹76 Cr₹119 Cr₹120 Cr₹140 Cr₹135 Cr₹98 Cr₹178 Cr₹95 Cr₹50 Cr₹25 Cr₹111 Cr₹60 Cr₹64 Cr₹66 Cr₹137 Cr₹78 Cr₹72 Cr₹67 Cr₹117 Cr₹90 Cr₹69 Cr₹74 Cr₹123 Cr₹96 Cr₹82 Cr₹95 Cr₹109 Cr₹63 Cr₹32 Cr₹42 Cr₹77 Cr₹53 Cr₹49 Cr₹35 Cr₹37 Cr₹58 Cr₹57 Cr₹47 Cr₹49 Cr₹48 Cr₹40 Cr
₹2 Cr-₹43 L₹4 Cr₹79 L₹2 Cr₹8 Cr₹68 L₹2 L₹2 Cr₹5 Cr₹29 L₹84 L₹70 L₹6 Cr₹48 L-₹94 L₹85 L₹1 Cr₹13 L₹82 L₹67 L₹2 Cr₹2 Cr₹3 Cr₹74 L₹3 Cr₹85 L₹92 L₹2 Cr₹2 Cr₹73 L₹54 L₹1 Cr₹2 Cr₹34 L₹25 L₹92 L₹93 L₹85 L₹79 L₹77 L₹26 L₹1 Cr₹1 Cr₹74 L₹2 Cr₹7 L₹12 L₹4 L₹1 Cr₹9 L₹10 L₹36 L₹21 L₹2 L₹5 L
₹46 Cr₹189 Cr₹101 Cr₹85 Cr₹104 Cr₹116 Cr₹134 Cr₹105 Cr₹128 Cr₹215 Cr₹77 Cr₹59 Cr₹52 Cr₹164 Cr₹63 Cr₹75 Cr₹120 Cr₹121 Cr₹140 Cr₹135 Cr₹98 Cr₹180 Cr₹97 Cr₹52 Cr₹26 Cr₹114 Cr₹60 Cr₹64 Cr₹68 Cr₹139 Cr₹79 Cr₹72 Cr₹69 Cr₹119 Cr₹90 Cr₹69 Cr₹75 Cr₹124 Cr₹97 Cr₹83 Cr₹95 Cr₹109 Cr₹64 Cr₹33 Cr₹43 Cr₹80 Cr₹53 Cr₹49 Cr₹35 Cr₹38 Cr₹58 Cr₹58 Cr₹47 Cr₹49 Cr₹48 Cr₹40 Cr
₹44 Cr₹186 Cr₹99 Cr₹82 Cr₹101 Cr₹113 Cr₹132 Cr₹102 Cr₹126 Cr₹212 Cr₹74 Cr₹56 Cr₹50 Cr₹161 Cr₹61 Cr₹72 Cr₹118 Cr₹119 Cr₹138 Cr₹132 Cr₹95 Cr₹176 Cr₹95 Cr₹50 Cr₹24 Cr₹111 Cr₹59 Cr₹63 Cr₹65 Cr₹135 Cr₹77 Cr₹70 Cr₹66 Cr₹115 Cr₹87 Cr₹67 Cr₹72 Cr₹119 Cr₹94 Cr₹81 Cr₹93 Cr₹108 Cr₹64 Cr₹32 Cr₹42 Cr₹79 Cr₹52 Cr₹48 Cr₹34 Cr₹38 Cr₹58 Cr₹56 Cr₹47 Cr₹49 Cr₹48 Cr₹40 Cr
₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹95 L₹83 L₹1 Cr₹1 Cr₹1 Cr₹67 L₹61 L₹100 L₹33 L₹60 L₹1 Cr₹57 L₹4 L₹62 L₹81 L
₹2 Cr₹2 Cr₹92 L₹1 Cr₹1 Cr₹1 Cr₹90 L₹2 Cr₹96 L₹1 Cr₹1 Cr₹1 Cr₹90 L₹1 Cr₹71 L₹59 L₹55 L₹59 L₹49 L₹61 L₹47 L₹56 L₹61 L₹80 L₹47 L₹37 L₹51 L₹46 L₹42 L₹66 L₹98 L₹42 L₹17 L₹62 L₹63 L₹32 L₹31 L₹100 L₹1 Cr₹85 L₹1 Cr₹43 L₹40 L₹40 L₹35 L₹38 L₹30 L₹27 L₹28 L₹20 L₹21 L₹20 L₹20 L₹15 L₹19 L₹18 L
₹52 L₹1 Cr₹92 L₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹73 L₹2 Cr₹75 L₹2 Cr₹80 L₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹56 L₹20 L₹45 L₹60 L₹41 L₹15 L₹27 L₹58 L-₹10 L₹25 L₹96 L₹24 L-₹29 L₹29 L₹50 L
₹1 Cr₹2 Cr₹57 L₹1 Cr₹1 Cr₹47 L₹72 L₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹78 L₹73 L₹36 L₹100 L₹2 Cr₹80 L-₹75 L₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹100 L₹1 Cr₹1 Cr₹2 Cr₹74 L₹2 Cr₹2 Cr₹2 Cr₹82 L₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹4 L₹20 L₹45 L₹60 L₹9 L₹15 L₹27 L₹58 L-₹25 L₹25 L₹81 L₹24 L-₹54 L₹29 L₹50 L

Share Price Live Stats

Open (₹)96.00
Volume (₹)87,741.00
High (₹)96.99
Upper Circuit99.16
Low (₹)93.55
Lower Circuit89.72
Prev Close94.44
52W High (₹)100.00
Price95.00
52W Low (₹)50.31

Share Market Cap & Key Ratios Overview

M.Cap (₹)292.81 Cr
Div. Yield (%)0.00
PE Ratio70.12
Debt to Equity0.26
Price to Book0.71
Book Value47.78
EPS (TTM)1.35
Face Value10.00
ROE (%)3.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
PREMIERENENSE
AEGISLOGNSE
CPPLUSNSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
ENTERONSE
AAREYDRUGSNSE
LTP
1W Low
1W High
Market cap (₹)
2937.6-230.9 (-7.29%)
2830.50
3165
3,90,684Cr
1000.8-13.1 (-1.29%)
995.10
1036.30
45,486Cr
1274.6-14.8 (-1.15%)
1180
1327.30
45,144Cr
3660.1+83.5 (2.33%)
3460.20
3797.90
44,346Cr
369.6+3.6 (0.98%)
343.70
378.80
29,113Cr
471.5+0.85 (0.18%)
464.60
492.60
15,566Cr
74.04+0.51 (0.69%)
69.51
74.69
10,984Cr
825.95+36.65 (4.64%)
785.50
859.95
10,266Cr
64.26+1.19 (1.89%)
61.41
66.20
9,342Cr
1831.9+23.3 (1.29%)
1742.60
1868.90
8,041Cr
95+5.99 (6.73%)
86.41
96.99
293Cr

Key Highlights of Aarey Drugs & Pharmaceuticals Ltd’s P&L

In 2025-03-31, Aarey Drugs & Pharmaceuticals Ltd reported total revenue of ₹473.94Cr, compared with ₹397.65Cr in 2024-03-31, reflecting Aarey Drugs & Pharmaceuticals Ltd turnover.

Depreciation was ₹1.94Cr and finance costs were ₹4.66Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹6.1Cr in 2025-03-31 as compared to ₹5.34Cr in 2024-03-31.

Net Profit (PAT) was ₹4.02Cr in 2025-03-31 compared with ₹4.68Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.41 in 2025-03-31, compared with ₹1.67 in 2024-03-31.